Showing results (361-370 of 579) with videos related to

Sort By:
Pageof 58
Journal of Hematology & Oncology|October 12, 2024
Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantationXin Kong, Ziyi Xu, Yanjun Wu, et al.
Frontiers in Immunology|May 18, 2026
Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemiaFengli Li, Yangyang Ding, Shanglong Feng, et al.
Bone Marrow Transplantation|March 29, 2020
Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 casesLimin Liu, Yanming Zhang, Wenjing Jiao, et al.
Bone Marrow Transplantation|November 25, 2020
Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantationJingsheng Hua, Jian Zhang, Xinyou Zhang, et al.
International Journal of Hematology|June 27, 2021
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remissionKangkang Lv, Chengsen Cai, Jia Chen, et al.
Annals of Hematology|April 22, 2021
The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimenPeng Ke, Xinyou Zhang, Songbai Liu, et al.
Cancer Genetics|July 4, 2012
Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCRHaoyue Chen, Jinlan Pan, Li Yao, et al.
Haematologica|February 20, 2025
Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemiaZiyu Feng, Xiaohui Hu, Weiyang Li, et al.
Blood|December 27, 2022
The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host diseaseQiao Cheng, Dong Wang, Xiaoxuan Lai, et al.
Molecular Oncology|September 2, 2022
Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYCWenjuan Ma, Yan Wan, Jianxiang Zhang, et al.
Pageof 58